JK
James Kihara sold $298K of ACAD stock
James Kihara, Principal Accounting Officer of Acadia Pharmaceuticals Inc (ACAD), sold 11,421 shares of ACAD stock worth $298K, per an SEC Form 4 filed Jun 29, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jun 26, 2026, 3 days before it was made public.
ACAD has moved -25.9% since the trade date, from $25.32 to $18.75 (Nov 13, 2026 close).
- Traded
- Jun 26, 2026
- Disclosed
- Jun 29, 2026
- Filing delay
- 3 days
- Price since
- -25.9%
- Role
- Principal Accounting Officer
- Source
- SEC Form 4